Ultrastructural features of cardiomyocytes in dilated cardiomyopathy with initially decompensated heart failure as a predictor of prognosis

European Heart Journal

Volumn 36, Issue 12, 2015, Pages 724-733

  Saito, Tsunenori ^a   Asai, Kuniya ^a   Sato, Shigeru ^a   Takano, Hitoshi ^a   Mizuno, Kyoichi ^a   Shimizu, Wataru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Dilated cardiomyopathy; Electron microscopy; Endomyocardial biopsy; Heart failure; Myofilament changes

Indexed keywords

GLYCOGEN; HEMOGLOBIN;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CANCER MORTALITY; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CELL DAMAGE; CELL ULTRASTRUCTURE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ELECTRON MICROSCOPY; EVALUATION STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; MORPHOMETRICS; MYOFILAMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RIBOSOME; SARCOMERE; SMOOTH ENDOPLASMIC RETICULUM; ACTIN FILAMENT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSPECTIVE STUDY; ULTRASTRUCTURE;

ACTIN CYTOSKELETON; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MYOCYTES, CARDIAC; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84938391372     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu404     Document Type: Article

References (24)

1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D, Framingham Heart Study. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068-3072.
2. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions [erratum published in N Engl J Med 1992:327:1768]. N Engl J Med 1992;327:685-691.
3. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000;101:2981-2988.
4. Azuma A, Matsuo A, Nakamura T, Kawasaki T, Yamamoto K, Hyogo M, Hirata A, Hirasaki S, Shima T, Sugihara H, Kunishige H, Kuribayashi T, Nakagawa M. Improved survival of idiopathic dilated cardiomyopathy in the 1990s. Jpn Circ J 1999;63:333-338.
5. Saito T, Asai K, Sato S, Takagi G, Takano H, Takahashi H, Yasutake M, Mizuno K. Myocardial alterations and clinical implications associated with recovery of cardiac function in dilated cardiomyopathy with obesity. Int J Cardiol 2013; 168:144-150.
6. nd ed. London: Hodder Arnold, 2011. pp. 133-192.
7. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-514.
8. Hammond EH, Menlove RL, Anderson JL. Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy. Am Heart J 1987;114:1055-1065.
9. Tanaka M, Kawahara Y, Motomiya T, Sakamoto M, Sugiura M, Toyoda M, Kajita A, Osamura Y. Cardiomyopathy characterized by abnormal accumulation of desmin-type intermediate filaments in cardiac muscle fibers. A case report and review of the literature. Acta Pathol Jpn 1989;39:266-273.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
11. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-1184.
12. Kawashima T, Yokota Y, Yokoyama M, Itoh H. Pathological analysis of hypertrophic cardiomyopathy simulating dilated cardiomyopathy. Acta Pathol Jpn 1993;43:304-312.
13. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED, Seidman JG, Seidman CE. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000;343:1688-1696.
14. Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, Gerdes AM, Capetanaki Y. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol 1999;31:2063-2076.
15. Vatta M, Stetson SJ, Perez-Verdia A, Entman ML, Noon GP, Torre-Amione G, Bowles NE, Towbin JA. Molecular remodelling of dystrophin in patients with endstage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet 2002;359:936-941.
16. Grünig E, Tasman JA, Kücherer H, Franz W, Kübler W, Katus HA. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998;31:186-194.
17. Rapezzi C, Arbustini E, Caforio AL, Charron P, Gimeno-Blanes J, Heliö T, Linhart A, Mogensen J, Pinto Y, Ristic A, Seggewiss H, Sinagra G, Tavazzi L, Elliott PM. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:1448-1458.
18. Ikeda T, Saito T, Takagi G, Sato S, Takano H, Hosokawa Y, Hayashi M, Asai K, Yasutake M, Mizuno K. Acute myocarditis associated with coxsackievirus B4 mimicking influenza myocarditis: electron microscopy detection of causal virus of myocarditis. Circulation 2013;128:2811-2812.
19. Ausma J, Wijffels M, Thoné F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163.
20. Mason JW, O'Connell JB. Clinical merit of endomyocardial biopsy. Circulation 1989;79:971-979.
21. Mattos BP, Zettler CG, Pinotti AF, Raudales JC, Zago AJ. Left ventricular function and endomyocardial biopsy in early and advanced dilated cardiomyopathy. Int J Cardiol 1998;63:141-149.
22. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-48.
23. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004;110:149-154.
24. Shimomura H, Terasaki F, Hayashi T, Kitaura Y, Isomura T, Suma H. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J 2001;65:965-968.